DIACOMIT DIN 02398958
Status: Marketed
Holder: BIOCODEX SAS
Available to quote
Health Canada record
| Active ingredient(s) | STIRIPENTOL 250 MG |
|---|
| Dosage form | Capsule |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | N03AX17 STIRIPENTOL |
|---|
| Original market date | 01-May-2013 |
|---|
| Current status date | 01-May-2013 |
|---|
| Source | Health Canada DPD |
|---|
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing STIRIPENTOL
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02398966 | DIACOMIT | BIOCODEX SAS | Capsule | STIRIPENTOL 500 MG | Marketed |
| 02398974 | DIACOMIT | BIOCODEX SAS | Powder For Suspension | STIRIPENTOL 250 MG | Marketed |
| 02398982 | DIACOMIT | BIOCODEX SAS | Powder For Suspension | STIRIPENTOL 500 MG | Dormant |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 13964 | 2012-12-21 | New Drug Submission (NDS) | |
International API supply for STIRIPENTOL
5 active FDA Drug Master Files.
Request a quote for DIACOMIT
How to read a Canadian DIN record